Multas ANVISA por Venda Irregular de Lentes Corretivas
Definition
Regulation forbids sale of corrective lenses outside specialized licensed shops; importers need ANVISA import licenses. Non-compliance results in penalties from ANVISA, classified as severe for post-market surveillance failures.
Key Findings
- Financial Impact: R$5,000+ fine per violation (typical ANVISA penalty range); up to 20% gross revenue for related antitrust breaches
- Frequency: Per irregular sale or import batch
- Root Cause: Manual process lacks automated checks for shop licensing, import licenses, and state health surveillance registration
Why This Matters
The Pitch: Optometrists in Brasil waste R$10,000+ annually on ANVISA penalties. Automation of license verification and NF-e issuance eliminates this risk.
Affected Stakeholders
Proprietários de Óticas, Gerentes de Compras, Importadores de Lentes
Deep Analysis (Premium)
Financial Impact
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Current Workarounds
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Get Solutions for This Problem
Full report with actionable solutions
- Solutions for this specific pain
- Solutions for all 15 industry pains
- Where to find first clients
- Pricing & launch costs
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.
Related Business Risks
Rejeição NF-e por Falta de Fatura de Origem em Óculos
Perdas por Estoque de Lentes sem Registro ANVISA
Erros de Precificação e Etiquetagem
Perdas por Estoque Parado e Vencido
Furtos e Avarias no Estoque
Perdas de Vendas por Falta de Estoque
Request Deep Analysis
🇧🇷 Be first to access this market's intelligence